As new and novel drug therapies are developed to address areas where conventional medicines are limited, drug delivery innovators, designers and manufacturers have turned to Picocyl for its unique, patented power solutions for drug and implant delivery systems.
Tonix Pharmaceuticals Announces Groundbreaking Ceremony for Massachusetts R&D Facility to House the Advanced Development Center (ADC) for Vaccine Programs
The ISO 7 class clean room can produce nine-layer blown film. The new installation fully encloses commercial-scale production of Berry’s proprietary nine-layer blown film from extrusion to packaging, a first in the United States. The addition further enhances Berry’s ability to supply more sensitive applications such as sterile intravenous solution bags, pharmaceutical packaging, medical equipment manufacturing, and microchip packaging.
Merck KGaA, Darmstadt, Germany today announced today announced moves designed to pave the way for an even more successful future in China. Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced today announced moves designed to pave the way for an even more successful future in China.
Novacap, a worldwide player in pharmaceutical synthesis and advanced specialties, announced today that it has signed an agreement to acquire Boston-based PCI Synthesis, a leading U.S. pharmaceutical contract development and manufacturing organization (CDMO), further reinforcing Novacap’s capabilities and offering for the pharmaceutical industry.
MIT engineers have developed a probiotic mix of natural and engineered a probiotic bacteria to diagnose and treat cholera, an intestinal infection that causes severe dehydration. Cholera outbreaks are usually caused by contaminated drinking water, and infections can turn fatal if not treated.
Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), today announced the publication of a study in Scientific Reports, a Nature Publishing Group journal, describing the development of the CubiCAR, an all-in-one Chime
E06 Antibody Blocks Inflammation, Protects Mice from Hardened Arteries and Liver Disease. Study uncovers new potential therapeutic approach for a number of diseases linked to inflammation, including atherosclerosis, aortic stenosis and hepatic steatosis
10 Easy steps to cleaning a contaminated surface in the biosafety cabinet. The biosafety cabinet is a laboratory workspace that ensures safety and cleanliness for both the person operating in the cleanroom as well as the products or materials being handled in the cleanroom. The biosafety cabinet creates a safe environment for working with drugs, chemicals or hazardous materials.
The feeding systems are a key part of the new continuous production concept. At Pfizer, the compact arrangement of pharmaceutical feeders supplied by Coperion K-Tron accurately deliver ingredients into the continuous mixing process, thereby guaranteeing consistent and very high quality end products.
Emergent BioSolutions Inc. (NYSE:EBS) today announced the beginning of a $50 million expansion to the company’s Camden fill/finish facility located in Baltimore, Md. The multi-year expansion is expected to be completed in 2021, and will significantly increase the company’s contract development and manufacturing capacity, redundancy, and flexibility.
MIT researchers, working with scientists from Brigham and Women’s Hospital, have developed a new way to power and communicate with devices implanted deep within the human body. Such devices could be used to deliver drugs, monitor conditions inside the body, or treat disease by stimulating the brain with electricity or light.